Full profile interview: Company Financials
5 Oct 2026

Sava Technologies
Full profile interview: IDTechEx Index
1 Jun 2026

Roche Diabetes Care
Full profile interview
17 May 2026

Abbott Diabetes Care
Abbott Diabetes Care is a division of American multinational company Abbott Laboratories. Today, Abbott Diabetes Care is a major player in the continuous glucose monitoring market — the company's "Freestyle" brand of continuous glucose monitors (CGMs) is believed to be the most widely used CGM device.
Included are:
Full profile interview: Company Financials
15 May 2026

Sinocare Inc
The largest individual funding stakeholder, directly controlling 25.8% of the company's equity
Background: Partnerships
25 Oct 2024

Insulet
Partnered with Dexcom to provide users access to CGM data from G-series of CGMs, enabling a hybrid closed loop insulin management system.
Full profile interview: SWOT
11 May 2022

GlucoRx
Background
8 Jul 2020

Abbott Diabetes Care
This is a comprehensive review of the business and technology of Abbott Diabetes Care, assembled from company reports and extensive academic literature review, and supported by additional interview comments over several years. It focuses primarily on the technology behind their market leading FreeStyle™ Libre™ CGM device, which generated over $1.8bn in revenue in 2019.
Included are:
Full profile interview: SWOT
20 Jan 2017

PKvitality
Full profile interview: SWOT
28 Nov 2016

DexCom Inc